Application 065354
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GRISEOFULVIN | GRISEOFULVIN, MICROSIZE | SUSPENSION;ORAL | 125MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-361 | grisofulvin | grisofulvin | Cipla USA Inc. | ANDA | Current |